Chronic renal failure, cachexia, and ghrelin.
Protein energy wasting is frequently observed in patients with advanced chronic renal failure and end-stage renal disease. Anorexia and reduced food intake are critical contributing factors and negatively impact on patients' survival. Ghrelin is a prophagic peptide produced by the stomach and acting at the hypothalamic level to increase the activity of orexigenic neurons. In patients with chronic renal disease, plasma levels are increased as a likely effect of reduced renal clearance. Nevertheless, patients' food intake is significantly reduced, suggesting inflammation-mediated resistance of hypothalamic nuclei to peripheral signals. A number of forms of evidence show that ghrelin resistance could be overcome by the administration of exogenous ghrelin. Therefore, ghrelin has been proposed as a potential strategy to improve food intake in chronic renal failure patients with protein energy wasting. Preliminary data are encouraging although larger prospective clinical trials are needed to confirm the results and to identify those patients who are likely to benefit most from the administration of exogenous ghrelin.
Laviano
A
A
Department of Clinical Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Krznaric
Z
Z
Sanchez-Lara
K
K
Preziosa
I
I
Cascino
A
A
Rossi Fanelli
F
F
Am J Clin Nutr. 2006 Apr;83(4):735-43
16600922
J Am Soc Nephrol. 2002 Nov;13(11):2748-52
12397045
Eur J Nutr. 2009 Apr;48(3):176-83
19198916
Clin Nutr. 2008 Feb;27(1):142-9
17854954
FASEB J. 2004 Mar;18(3):439-56
15003990
Cell Metab. 2009 Jun;9(6):489-98
19490904
Horm Metab Res. 2005 Oct;37(10):646-52
16278789
J Ren Nutr. 2007 Jan;17(1):13-6
17198926
Am J Clin Nutr. 2004 Aug;80(2):299-307
15277149
Clin Nutr. 2008 Dec;27(6):793-9
18718696
Pediatr Nephrol. 2008 Jan;23(1):41-8
17676425
Endocrinology. 2008 Feb;149(2):827-35
18039782
Cell Metab. 2008 May;7(5):389-99
18460330
J Am Soc Nephrol. 2005 Jul;16(7):2111-8
15888560
Hemodial Int. 2006 Oct;10(4):315-25
17014506
Nephrol Dial Transplant. 2009 Feb;24(2):643-6
18809976
Am J Kidney Dis. 2006 Jul;48(1):37-49
16797385
Am J Physiol Renal Physiol. 2009 Oct;297(4):F1032-7
19625378
Nat Rev Neurosci. 2001 Aug;2(8):551-60
11483998
J Ren Nutr. 2009 May;19(3):248-55
19243975
Adv Chronic Kidney Dis. 2009 Nov;16(6):501-10
19801138
Peptides. 2009 Oct;30(10):1909-13
19577604
Nat Neurosci. 2005 May;8(5):571-8
15856065
J Am Soc Nephrol. 2007 Sep;18(9):2517-24
17687077
J Ren Nutr. 2009 Jan;19(1):20-4
19121765
Infect Disord Drug Targets. 2009 Aug;9(4):376-89
19689380
Endocr Rev. 2010 Feb;31(1):25-51
19861693
Nephrol Dial Transplant. 2004 Aug;19(8):2095-100
15187192
J Hum Nutr Diet. 2009 Aug;22(4):343-50
19624402
J Int Med Res. 2008 May-Jun;36(3):522-8
18534134
Kidney Int. 2009 Jul;76(2):199-206
19387475
Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):378-83
19474712
Kidney Int. 2007 Jan;71(2):146-52
17063174
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1000-8
18713954
J Ren Nutr. 2006 Jul;16(3):208-11
16825021
J Clin Invest. 2005 Jun;115(6):1659-65
15931394
J Clin Invest. 2007 Jan;117(1):13-23
17200702
Pharmacol Rev. 2009 Dec;61(4):430-81
20038570
Hypertension. 2009 Nov;54(5):995-1000
19786648
Biol Psychiatry. 2008 Jan 15;63(2):245-7
17706613
Am J Nephrol. 2007;27(4):360-5
17556836
Kidney Int. 2010 Jan;77(1):23-8
19890275